AstraZeneca, a global leader in biopharmaceutical innovation, is excited to announce a significant funding milestone that will propel its ongoing mission to revolutionize healthcare for communities worldwide. As part of our commitment to advancing medical science and addressing pressing health challenges, we have successfully secured $1 billion in funding from key investors and strategic partners. This investment will be strategically allocated to enhance our research and development initiatives, specifically focusing on groundbreaking therapies that target critical areas such as oncology, cardiovascular disease, and respiratory health. In alignment with our vision of unlocking the power of science for the betterment of society and the planet, this funding will also support the establishment of sustainable and equitable healthcare solutions, ensuring that advancements reach those who need them most. As we reflect on this pivotal moment, we are reminded that our collaborative efforts with investors, healthcare professionals, and communities play a vital role in creating a healthier future. AstraZeneca remains dedicated to leveraging cutting-edge technology and innovative research to meet the evolving needs of patients globally. We invite you to join us on this transformative journey as we continue to push the boundaries of what is possible in healthcare. For more information about our initiatives and ongoing projects, please visit our website at www.astrazeneca.com.
AstraZeneca Raises Capital to Revolutionize Healthcare: Unleashing the Power of Science
BioPharmaceutical
Get the full AstraZeneca company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Laihua Online
Wuhan Laihua Information and Technology is an Internet leading source of information on educational opportunities for students to study in other countries especially in China. Either prospect is planning to come to China or is already in China for education (self-support or scholarship based) he will probably need one of the ranges of services we provide from Education, Translation, Notarization of legal documents to Internships & Jobs or Medical Tourism etc. It is a comprehensive directory of study abroad programs, including summer study abroad, service learning, intensive language programs and more. Wuhan Laihua Information and Technology first set out to fill the information gap between students with a desire to travel abroad to study and companies offering international programs.
$68.0M Series d
today
NEW ID
NEW ID is the latest subsidiary company of NEW, which has started up since August 2019 for a new digital contents/platform business domain. We are responsible for expanding the contents produced and acquired by NEW into various markets and creating our digital capabilities through partnering with a-lister digital content creators and providers in Korea.
